General Partner Inc’s GSK GSK Stock Holding History

General Partner Inc’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-160	Closed	-$6.14K	–	172
2025 Q2	$6.14K	Hold	160	–	–	﹤0.01%	165
2025 Q1	$6.2K	Hold	160	–	–	﹤0.01%	166
2024 Q4	$5.41K	Buy	+160	New	+$5.76K	﹤0.01%	166

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

General Partner Inc's GSK Position: Q3 2025 in Review

General Partner Inc sold out of GSK (GSK) in Q3 2025, closing a stake of 160 shares — an estimated $6.14K sold.

General Partner Inc first reported a position in GSK in Q4 2024 and held it in 3 quarters. The position peaked at $6.2K in Q1 2025. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

General Partner Inc reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
General Partner Inc sold 160 GSK shares in Q3 2025, an estimated $6.14K.
General Partner Inc first reported a position in GSK in Q4 2024 and held it in 3 quarters.
General Partner Inc's GSK position peaked at $6.2K in Q1 2025.
895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on General Partner Inc's 13F filing for Q3 2025, filed 8 Oct 2025.